For the state, the cost of funding obesity medications was too high. For the patients, the cost of losing access is higher.

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: 'SlimCell™' with Clinically Proven Ingredients to Compliment GLP-1 ...

A slowdown of the digestive tract (gastroparesis) can be a serious side effect, though. Researchers who analyzed the health records of 16 million people revealed that pancreatitis and bowel ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

A recent study has found that semaglutide reduced heart muscle mass in both lean and obese mice, as well as in lab-grown ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Medications like Ozempic and Wegovy have made waves for weight loss, but they’re not for everyone. If you’ve been put off by ...

Popular weight loss drug, semaglutide, could be shrinking the muscle tissue in the heart, a new study has found. In recent ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

In "Black Market Weight Loss," RTÉ Investigates goes undercover to examine how prescription-only weight loss medication is ...